Stockscreener 앱 받기
5.45
5.62%
0.29
전일 마감가:
$5.16
열려 있는:
$5.17
하루 거래량:
2.55M
Relative Volume:
17.83
시가총액:
$369.77M
수익:
$64.49M
순이익/손실:
$-71.40M
주가수익비율:
-5.00
EPS:
-1.09
순현금흐름:
$-52.00M
1주 성능:
+3.02%
1개월 성능:
+13.31%
6개월 성능:
+50.55%
1년 성능:
+82.89%
1일 변동 폭
$5.00
$5.50
1주일 범위
$4.62
$5.545
52주 변동 폭
$2.58
$5.545
Sophia Genetics Sa Stock (SOPH) Company Profile
SOPH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SOPH
Sophia Genetics Sa
|
5.45 | 350.09M | 64.49M | -71.40M | -52.00M | -1.09 |
|
VEEV
Veeva Systems Inc
|
222.21 | 35.99B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
70.33 | 12.26B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
41.26 | 7.73B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
85.37 | 7.43B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
39.20 | 7.14B | 11.99B | 24.18M | 234.31M | 0.2956 |
Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-18 | 개시 | Craig Hallum | Buy |
| 2024-08-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-06-27 | 개시 | Guggenheim | Buy |
| 2023-11-29 | 개시 | RBC Capital Mkts | Outperform |
| 2023-07-05 | 재개 | JP Morgan | Overweight |
| 2023-01-03 | 개시 | BTIG Research | Buy |
| 2022-11-23 | 개시 | Credit Suisse | Neutral |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-08-17 | 개시 | Cowen | Outperform |
| 2021-08-17 | 개시 | Credit Suisse | Outperform |
| 2021-08-17 | 개시 | JP Morgan | Overweight |
| 2021-08-17 | 개시 | Morgan Stanley | Overweight |
모두보기
Sophia Genetics Sa 주식(SOPH)의 최신 뉴스
Sentiment Review: Why is SOPHiA GENETICS SA stock going downJuly 2025 Drop Watch & Stock Timing and Entry Methods - baoquankhu1.vn
Aug Levels: Is SOPHiA GENETICS SA stock a hidden gemJuly 2025 Review & Risk Managed Trade Strategies - baoquankhu1.vn
Inside the platform analyzing 1.8M genomes to speed cancer insights - Stock Titan
Executive hires to help startups scale - Startupticker.
Aug Final Week: Is SOPHiA GENETICS SA a potential multi baggerQuarterly Market Summary & Safe Capital Investment Plans - baoquankhu1.vn
SOPHiA GENETICS Announces CEO Transition and Strong Preliminary 2025 Results - TipRanks
SOPHiA GENETICS Provides Preliminary Fourth Quarter and Full Year 2025 Financial Results, Initiates 2026 Guidance, and Announces Executive Transition Plan - marketscreener.com
SOPHiA GENETICS Provides Preliminary Fourth Quarter and Full Year 2025 Financial Results, Initiates 2026 Guidance, and Announces Executive Transition Plan (2026-01-12) - Seeking Alpha
SOPHiA GENETICS Reports Strong Q3 Growth and Raises Guidance - MSN
Can SOPHiA GENETICS SA (90B) stock ride next bull market cycleJuly 2025 Action & Growth Oriented Trade Recommendations - Улправда
Will SOPHiA GENETICS SA stock maintain dividend yieldMarket Sentiment Review & Daily Risk Controlled Trade Plans - Улправда
Why SOPHiA GENETICS SA stock remains on buy listsQuarterly Portfolio Review & Scalable Portfolio Growth Ideas - Улправда
Why analysts recommend SOPHiA GENETICS SA (90B) stock2025 Valuation Update & Weekly Watchlist for Consistent Profits - Улправда
Published on: 2026-01-09 00:00:10 - Улправда
Will SOPHiA GENETICS SA (90B) stock outperform global peersJuly 2025 Market Mood & High Accuracy Trade Alerts - ulpravda.ru
Is SOPHiA GENETICS SA stock ready for breakoutQuarterly Market Summary & Free Safe Entry Trade Signal Reports - Улправда
Income Plays: Can SOPHiA GENETICS SA (90B) stock ride next bull market cycleWeekly Investment Recap & High Return Stock Watch Alerts - Улправда
Aug Sectors: Is SOPHiA GENETICS SA stock ready for breakoutWeekly Trade Analysis & Long Hold Capital Preservation Tips - Bộ Nội Vụ
How SOPHiA GENETICS SA stock benefits from global expansionStock Rotation Strategies & Access Free Risk Analysis Before You Invest - ulpravda.ru
Tech Rally: Will SOPHiA GENETICS SA 90B stock outperform global peers2025 Market Outlook & Free Fast Entry Momentum Trade Alerts - Bộ Nội Vụ
Sophia Genetics stock rises on MD Anderson Cancer Center partnership - Investing.com
SOPHiA GENETICS and MD Anderson Announce Strategic Collaboration to Accelerate AI-Driven Precision Oncology - Finviz
MD Anderson, SOPHiA GENETICS Join for AI Oncology Boost - Mirage News
SOPHiA GENETICS and MD Anderson partner on AI-driven cancer care - Investing.com UK
Analyzing SOPHiA GENETICS (NASDAQ:SOPH) and Clover Health Investments (NASDAQ:CLOV) - Defense World
Will SOPHiA GENETICS SA stock benefit from upcoming earnings reports2026 world cup usa national team semifinals star players low block defense group prediction expert opinion - ulpravda.ru
Can Nirlon Limited (500307) Maintain Its ValuationMarket Capitalization Trends & Our Picks = Your Future Gains - bollywoodhelpline.com
RSI Reset May Fuel Rebound in Sanstar LimitedMerger & Acquisition Updates & Outperform With Our Smart Trading Calculator - bollywoodhelpline.com
Analysts Offer Insights on Healthcare Companies: Adaptive Biotechnologies (ADPT), UCB SA (GB:0NZT) and Cibus (CBUS) - The Globe and Mail
SOPHiA GENETICS SA (NASDAQ:SOPH) Short Interest Update - Defense World
Reviving an old journey post retirementTrading Volume Surges & Build a Dividend-Powered Portfolio - bollywoodhelpline.com
SOPHiA GENETICS (NASDAQ:SOPH) Trading 2.8% HigherWhat's Next? - MarketBeat
SOPHiA GENETICS (NASDAQ:SOPH) Trading 2.8% Higher – What’s Next? - Defense World
Mukta Agriculture Limited Hits Oversold Level on RSI IndicatorHealthcare Stock Analysis & Real-Life Case Studies You Can Follow - bollywoodhelpline.com
Aug Chart Watch: Is SOPHiA GENETICS SA stock a buy before product launchesRisk Management & Stepwise Swing Trade Plans - moha.gov.vn
Swiss stocksFactors to watch on December 23 - marketscreener.com
A activityMarket Sentiment Report & Trade Opportunity Analysis Reports - Улправда
What is the fair value of SOPHiA GENETICS SA stock nowQuarterly Risk Review & Real-Time Volume Analysis Alerts - Улправда
Why SOPHiA GENETICS SA (90B) stock remains stableRecession Risk & Reliable Breakout Stock Forecasts - Улправда
What makes SOPHiA GENETICS SA stock attractive to growth fundsJuly 2025 Breakouts & Low Drawdown Investment Strategies - Улправда
VP Menu Files To Sell 608 Of SOPHiA GENETICS SA [SOPH] - TradingView — Track All Markets
Will SOPHiA GENETICS SA stock gain from government policies2025 Key Lessons & Real-Time Buy Signal Notifications - Улправда
Will SOPHiA GENETICS SA (90B) stock profit from fiscal stimulusPortfolio Performance Report & Safe Swing Trade Setup Alerts - DonanımHaber
Will SOPHiA GENETICS SA stock maintain momentum in 2025Weekly Trend Summary & Long-Term Capital Growth Strategies - Улправда
Can SOPHiA GENETICS SA stock maintain growth trajectoryPortfolio Performance Report & Expert Curated Trade Setup Alerts - Улправда
Can SOPHiA GENETICS SA (90B) stock beat analyst consensus2025 Stock Rankings & Verified Momentum Stock Ideas - DonanımHaber
Is SOPHiA GENETICS SA stock a buy before product launches2025 Earnings Impact & Growth Oriented Trading Recommendations - DonanımHaber
Can SOPHiA GENETICS SA stock beat market expectations this quarterGold Moves & Weekly Breakout Watchlists - Улправда
Is SOPHiA GENETICS SA (90B) stock worth holding before Fed meetingMarket Sentiment Summary & Stock Timing and Entry Methods - Улправда
Will FinWise Bancorp stock attract ESG investorsJuly 2025 Price Swings & Real-Time Volume Spike Alerts - Улправда
Oncology Biotech Challenges Rival's Cancer Testing Patent - Law360
Sophia Genetics Sa (SOPH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.21%
2.88%
자본화:
|
볼륨(24시간):